>IDIX – Isn't [IDX184] the one derived from Metabasis' "proprietary liver- targeting technology?"<
I, too, originally thought this to be the case, based on circumstantial evidence. However, JP Sommadossi has emphasized on recent webcasts that the discovery effort for IDX184 (and the rest of IDIX’s pipeline) was done in-house.
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”